Medical/Pharmaceuticals
Biosyngen received the Asia Pacific Cell & Gene Therapy Excellence Awards (APCGTEA) 2023
SINGAPORE, Sept. 18, 2023 /PRNewswire/ -- On September 14, 2023, Biosyngen Pte Ltd (hereinafter referred to as "Biosyngen") was the recipient of the prestigious "Most Promising Cell Therapy Pipeline in APAC" award at the 7th Annual Cell & Gene Therapy World Asia 2023, amidst a pool of internation...
2023-09-18 17:53
2915
Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients
HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- During the 23th ERS International Congress onSeptember 11, Broncus announced long-term follow-up data about Bronchoscopic Thermal Vapor Ablation (BTVA) treatment using InterVapor®, the Company's product for the treatment of Chronic Obstructive Pulm...
2023-09-18 17:36
3593
Global Times: China's medical assistance boosts healthcare development in South Pacific region
BEIJING, Sept. 18, 2023 /PRNewswire/ -- "For this surgery, we have prepared for more than half a year," Xiao Yuehai told the Global Times when talking about the first laparoscopic surgery carried out inSolomon Islands. Xiao is an urologist from the Affiliated Hospital of Guizhou Medical Universi...
2023-09-18 17:13
2681
Peak Asia Pacific fertility body endorses reform blueprint to create more family friendly societies
ADELAIDE, Australia, Sept. 18, 2023 /PRNewswire/ -- A unique reform blueprint to advance family friendly policies and arrest falling birth rates will be championed across theAsia Pacific by the peak body representing scientists, doctors, nurses and counsellors in assisted reproduction in the regi...
2023-09-18 09:26
2338
Biotropics Malaysia Berhad Unveils Novel Brain Health Ingredient at Vitafoods Asia 2023
BANGKOK, Sept. 18, 2023 /PRNewswire/ -- September 20, 2023, Biotropics Malaysia Berhad, a leading producer of high-quality botanical extracts, is pleased to announce the launch of its novel BioKesum® leaf extract clinically shown to support brain health. BioKesum® leaf extract is sourced from the...
2023-09-18 08:00
2793
New drug class prevents key ageing mechanism in organ transplants
ATHENS, Greece, Sept. 18, 2023 /PRNewswire/ -- A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of ageing, in recipients of older donor organs. The pioneering research, presented today at the European Societ...
2023-09-18 06:01
2884
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection
GAITHERSBURG, Md., Sept. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...
2023-09-15 20:30
3265
MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP
HONG KONG, Sept. 15, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ("HKSTP"), the city's largest R&D base and one of the most important incubators. ...
2023-09-15 18:35
3506
Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000
ZURICH, Sept. 15, 2023 /PRNewswire/ -- Neoss Group, a leading innovator in
dental implant solutions, is proud to announce the fast and easy-to-use
wireless intraoral scanner, NeoScan™ 2000. This follows the success of last
year's launch of the NeoScan™ 1000.
2023-09-15 16:00
2735
Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023
SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2023 is pleased to honor 30 outstanding business leaders and enterprises for championing sustainable and responsible business practices. Presented by leading regional NGO Enterprise Asia, the AREA is the mo...
2023-09-15 11:37
2596
MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers
SINGAPORE, Sept. 15, 2023 /PRNewswire/ -- MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional gen...
2023-09-15 11:00
3593
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
GENEVA, Sept. 15, 2023 /PRNewswire/ -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimu...
2023-09-15 08:00
3299
Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease
REYKJAVIK, Iceland, Sept. 14, 2023 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and TheCopenhagen University, publish a study today in the journal Cell titled "Complex effects of sequence variants on lipid level...
2023-09-14 23:00
3644
Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation"
Indonesian Minister of Health, Budi Gunadi Sadikin, emphasized that investing in the Health Technology and Biotechnology sector serves not only business prospects but also strengthens Indonesia's health resilience and adds value to healthcare. JAKARTA, Indonesia, Sept. 14, 2023 /PRNewswire/ -- F...
2023-09-14 17:47
2683
Neoss® Group launches NeoTell™ a new device to measure implant stability.
ZÜRICH, Sept. 14, 2023 /PRNewswire/ -- Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring. Today, we proudly introduce the first fruit of this col...
2023-09-14 16:00
2683
Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan
SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials inJapan. The former specialises in clinical trial site recruitment and retention and project managemen...
2023-09-14 10:00
4522
Avasa raises $1.55M in oversubscribed funding round with innovative implantable devices
MIAMI and AUCKLAND, New Zealand, Sept. 14, 2023 /PRNewswire/ -- Avasa, a medical device pioneer advancing surgical techniques for improved patient outcomes, announces the successful completion of its recent funding, raising an impressive$1.55 million in capital investment. The influx of new inves...
2023-09-14 04:50
3174
AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL
* AWAK closes one of the largest MedTech fundraise in 2023 in Southeast Asia * The Series B round was co-led by new investor Lion X Ventures and long-term investor Vickers Venture Partners, along with other new and existing investors * AWAK's ultra-portable peritoneal dialysis system enables ...
2023-09-13 21:27
4188
Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor
— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial intelligence (AI) platform, with potent activity in BRCA-mutated tumor models — — In May 2023, the U.S. Food and Drug Administration (FDA) cleared Insilico's I...
2023-09-13 20:29
4280
Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets
SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 ...
2023-09-13 10:30
4360
Week's Top Stories
Most Reposted
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 275 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00Ready Server Launches ReadyServer LLM API, Giving Every VPS Customer Private AI Inference at No Extra Cost
[Picked up by 265 media titles]
2026-10-20 14:10Most Read
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
2026-10-19 13:18
11371
FinDev Canada provides a USD 60 million loan to Muangthai Capital to advance gender equality and private sector investment in Thailand
2026-10-17 00:54
11260
BUUU Group Limited Announces 10-for-1 Forward Share Split
2026-10-17 04:30
10575